Review Series: Chronic Lymphoid Leukemia: Update on Immunological Dysfunctions and Infections. Since 2012

Guest Editors: D. Efremov and L. Laurenti

TOLL-LIKE RECEPTORS IN CHRONIC LYMPHOCYTIC LEUKEMIA
Marta Muzio, Eleonora Fonte, Federico Caligaris-Cappio | DOI: 10.4084/mjhid.2012.055e2012055
REGULATORY T-CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA
Giovanni D'arena, Giovanni Rossi, Barbara Vannata, Silvia Deaglio | DOI: 10.4084/mjhid.2012.053e2012053
THE SPECTRUM OF GENETIC DEFECTS IN CHRONIC LYMPHOCYTIC LEUKEMIA
Davide Rossi, Marco Fangazio, Gianluca Gaidano | DOI: 10.4084/mjhid.2012.076e2011076
IMMUNOGLOBULIN GENE REPERTOIRE IN CHRONIC LYMPHOCYTIC LEUKEMIA: INSIGHT INTO ANTIGEN SELECTION AND MICROENVIRONMENTAL INTERACTIONS
Efterpi Kostareli, Maria Gounari, Andreas Agathangelidis, Kostas Stamatopoulos | DOI: 10.4084/mjhid.2012.052e2012052
NOVEL AGENTS AND EMERGING STRATEGIES FOR TARGETING THE B-CELL RECEPTOR PATHWAY IN CLL
Dimitar Efremov, Adrian Wiestner, Luca Laurenti | DOI: 10.4084/mjhid.2012.067e2012067
INFECTIOUS COMPLICATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA
AnnaMaria Nosari | DOI: 10.4084/mjhid.2012.070e2012070

“IDENTIFYING HIGH-RISK CHRONIC LYMPHOCYTIC LEUKEMIA: A PATHOGENESIS-ORIENTED APPRAISAL OF PROGNOSTIC AND PREDICTIVE FACTORS IN PATIENTS TREATED WITH CHEMOTHERAPY WITH OR WITHOUT IMMUNOTHERAPY.”

Sara Martinelli, Antonio Cuneo, Gian Matteo Rigolin

DOI: 10.4084/mjhid.2016.047

 

PDF

 

HTML

 

e2016047

BCR SIGNALING INHIBITORS: AN OVERVIEW OF TOXICITIES ASSOCIATED WITH IBRUTINIB AND IDELALISIB IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA

Lorenzo Falchi, Jessica M Baron, Carrie Anne Orlikowski, Alessandra Ferrajoli

DOI: 10.4084/mjhid.2016.011

 

PDF

 

HTML

 

e2016011


 
© PAGEPress 2008-2017     -     PAGEPress is a registered trademark property of PAGEPress srl, Italy.     -     VAT: IT02125780185